According to reports, Cantor Fitzgerald CEO Howard Lutnick is now in the running to become President-elect Trump's Treasury ...

In a report released yesterday, Brett Knoblauch from Cantor Fitzgerald maintained a Buy rating on CSG Systems International (CSGS – ...

Cantor Fitzgerald analyst Derek Soderberg reiterated a Buy rating on Complete Solaria (CSLR – Research Report) yesterday and set a price target of $6.00. The company’s shares closed yesterday at $1.85 ...

Some investment and wealth management firms take a portfolio approach to the Employment and Investment Incentive Scheme (EIIS) but for Cantor Fitzgerald it’s more about identifying the right project ...

Howard Lutnick, CEO of private investment bank Cantor Fitzgerald, is a top ally of Trump who is heading his transition team. Since Trump’s blowout election victory last Tuesday, Lutnick has been ...

Fintel reports that on November 7, 2024, Cantor Fitzgerald upgraded their outlook for Sarepta Therapeutics (NasdaqGS:SRPT) from Neutral to Overweight. As of October 22, 2024, the average one-year ...

Fintel reports that on November 7, 2024, Cantor Fitzgerald upgraded their outlook for Sarepta Therapeutics (NasdaqGS:SRPT) ...

Small caps’ (NYSEARCA:IWM), (SP600) outperformance should continue into the year-end, according to Eric Johnston, senior managing director at Cantor Fitzgerald, in a bi-weekly report.

On Friday, Cantor Fitzgerald adjusted its outlook on Lucid Group Inc. (NASDAQ:LCID), reducing the price target to $3.00 from the previous $4.00, while keeping a Neutral rating on the stock.